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The Cytosolic Endopeptidase, Thimet Oligopeptidase,
Destroys Antigenic Peptides and Limits the Extent
of MHC Class I Antigen Presentation
membrane for display to T cells. This process allows
the immune system to monitor for the presence of cells
bearing foreign peptides—for example, ones derived
from viral or mutated proteins.
It is unclear whether antigenic peptides (or longer
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from hydrolysis by cytosolic peptidases. Some antigenicUniversity of Massachusetts Medical School
Worcester, Massachusetts 01655 peptides or larger precursors have been found in associ-
ation with heat shock proteins (Srivastava et al., 1998)2 Department of Cell Biology
Harvard Medical School or in other high molecular weight complexes (Paz et
al., 1999). It has been proposed that such interactionsBoston, Massachusetts 02155
3 Department of Biochemistry and Medicine protect these peptides from destruction by cytosolic
enzymes until they are translocated into the ER. It hasBoston University School of Medicine
Boston, Massachusetts 02118 also been suggested that proteasomes discharge their
products directly into the TAP transporter (Hirsch and
Ploegh, 2000). Such a mechanism would also protect
peptides from hydrolysis in the cytosol. However, thereSummary
is presently no evidence for either mechanism, each
of which has been proposed to account for the highMost antigenic peptides presented on MHC class I
molecules are generated by proteasomes during pro- efficiency of peptide presentation that has been re-
ported for certain peptides (Villanueva et al., 1994).tein breakdown. It is unknown whether these peptides
are protected from destruction by cytosolic pepti- Saric et al. (2001) found that a variety of antigenic
peptides were rapidly degraded when added to cyto-dases. In cytosolic extracts, most antigenic peptides
are degraded by the metalloendopeptidase, thimet oli- solic extracts. Although cell extracts contained many
exo- and endopeptidases capable of degrading oligo-gopeptidase (TOP). We therefore examined whether
TOP destroys antigenic peptides in vivo. When TOP peptides, one endopeptidase, thimet oligopeptidase
(TOP, EC3.4.25.15), was particularly active in degradingwas overexpressed in cells, class I presentation of
antigenic peptides was reduced. In contrast, TOP most of the antigenic peptides tested (Saric et al., 2001).
TOP is a cytosolic metallopeptidase that hydrolyzes oli-overexpression didn’t reduce presentation of peptides
generated in the endoplasmic reticulum or endo- gopeptides (typically of 6–17 residues) but not larger
polypeptides or proteins (Barrett et al., 1995). A varietysomes. Conversely, preventing TOP expression with
siRNA enhanced presentation of antigenic peptides. of functions for TOP have been proposed that involve
its attacking substrates in the extracellular space, e.g.,TOP therefore plays an important role in vivo in de-
grading peptides released by proteasomes and is a degrading neurotransmitters or amyloid  peptide (Vin-
cent et al., 1997; Yamin et al., 1999). Recent findingssignificant factor limiting the extent of antigen presen-
tation. indicate that in cell extracts, TOP is primarily responsible
for further degradation of most larger peptides produced
by the proteasome (T.S. et al., unpublished data). How-Introduction
ever, it is unknown whether TOP can actually destroy
antigenic peptides or their longer precursors in intactCellular proteins are continuously degraded by protea-
somes into oligopeptides ranging in size from about 3 cells or whether those peptides that are presented on
MHC class I molecules are protected from this enzymeto 24 residues (Kisselev et al., 1999; Rock and Goldberg,
1999; Rock et al., 2002). Most of these oligopeptides and other cytosolic peptidases. The present studies
were undertaken to test whether antigenic peptides re-are rapidly hydrolyzed by cytosolic peptidases to amino
acids (Goldberg et al., 2002), which are then re-utilized leased by proteasomes in the cytosol are susceptible
to destruction by cytosolic peptidases, especially TOP.in protein synthesis or energy production. However, in
mammalian cells, a small fraction of these peptides are
transported into the endoplasmic reticulum (ER), where, Results
if they have the correct motif and are 8–10 residues
long, they become tightly bound by specific MHC class Effect of TOP Overexpression on the Presentation of
I molecules (Rock and Goldberg, 1999). These peptide- Peptides Expressed in the Cytosol from Minigenes
MHC complexes are then transported to the plasma To test whether TOP can influence antigen presentation,
we initially studied the effects of transiently overex-
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Immunity
430
Figure 1. TOP Overexpression Inhibits MHC Class I Presentation of Cytosolic SIINFEKL
(A) The activities of TOP, aminopeptidases (AP), prolyl oligopeptidase (POP), or trypeptidyl peptidase II (TPPII) were measured as described
in Saric et al., 2001, in extracts from COS-Kb cells transfected for 48 hr with pTracer or pTracer-TOP or E36-Kb or DAP-Kb infected for 3 hr
with vaccinia virus TOP (VV-TOP) or vaccinia virus-gal (VV-gal). The data are expressed as the fold-increase in activity in TOP-transfected
cells compared to control cells. The coefficient of variation in all groups was 10%.
(B) COS-Kb cells were cotransfected with a SIINFEKL minigene in pCDNA3 (or empty pCDNA3 [No Ova]) and a pTracer CMV plasmid encoding
GFP (Vector), GFP  human TOP (TOP), or GFP  the control protein ORP150 (ORP150), and after 48 hr stained for SIINFEKL  Kb complexes
with 25.D1.16 or an isotype control (Bkg). For clarity the background fluorescence of only one group is shown because it was essentially
identical for all others (mean fluorescence intensity [MFI]  SD for the background on all groups  14.6 / 1.6). MFI were Bkg, 15.8; No
OVA,16.8; TOP, 214; Vector, 875; and ORP150, 922 fluorescent units.
(C) E36-Kb APCs were infected with vaccinia-T7 polymerase and either vaccinia-TOP or vaccinia-gal and then transfected with a SIINFEKL
minigene under the control of a T7 promoter in a pBluescript plasmid. After 1.25 hr the cells were fixed with 1% paraformaldehyde and the
indicated number incubated with the SIINFEKL  Kb specific T cell hybrid, RF33.70. IL-2 production by RF33.70 is displayed.
(D) Similar to (B) except E36-Db cells were used instead of E36-Kb, vaccinia-T7 polymerase was omitted, and after 1.5 hr cells were superinfected
for 1.5 hr with a vaccinia recombinant expressing ASNENMETM (a gift from J. Yewdell, NIH) instead of being transfected with a SIINFEKL
minigene, and the 12.3 hybridoma (Deckhut et al., 1993) (gift from D. Woodland, Trudeau Institute, NY) was used instead of RF33.70.
(E) Similar to (B) except that a KVVRFDKL minigene was used instead of SIINFEKL, the 1G8 hybridoma (Cole et al., 1994) (gift from J. McCluskey,
Flinders Medical Center) was used instead of RF33.70, and the transfection time was 2.5 hr.
expression vectors encoding SIINFEKL and TOP plus cinia virus and present antigens well to T cell hybrido-
mas ((Michalek et al., 1993; our unpublished data).green fluorescent protein (GFP) (which allowed trans-
fected cells to be identified) or control plasmids (GFP H-2Kb-expressing E36 cells (E36-Kb) were infected with
vaccinia-TOP and vaccinia-T7 and transfected with aalone; or an irrelevant protein, ORP150, plus GFP) were
transiently cotransfected into H-2Kb-expressing COS7 plasmid containing the SIINFEKL minigene under the
control of a T7 promoter. The presence of SIINFEKL oncells (COS-Kb). The presentation of SIINFEKL on H-2Kb
molecules was then detected by staining with a SIIN- H-2Kb molecules was assayed by measuring the produc-
tion of IL-2 from a specific T cell hybridoma. In cellsFEKLKb-specific monoclonal antibody (25.D1.16) (Por-
gador et al., 1997) and quantified by flow cytometry. infected with the TOP-encoding vaccinia vector the en-
zymatic activity of TOP was increased about 4- to 5-foldIn the TOP-transfected COS-Kb cells, TOP activity was
increased 16-fold (Figure 1A), and the generation of SI- (Figure 1A). The presentation of SIINFEKL on H-2Kb was
markedly inhibited in the cells overexpressing TOP com-INFEKL-Kb complexes was markedly reduced to levels
below those detected in cells expressing control pro- pared to cells infected with a vaccinia control (express-
ing lacZ) (Figure 1C). Similar results were obtained inteins GFP or ORP150 (Figure 1B).
We sought to confirm and extend these results in experiments performed with DAP cells (see Figure 4C
below). Therefore, TOP in at least three different cellother APCs. Since most APCs (unlike COS7 cells) do
not replicate plasmids episomally, we constructed a re- types from different species can limit the presentation
of SIINFEKL expressed in the cytoplasm.combinant vaccinia virus expressing TOP and used the
vaccinia T7-polymerase system to express antigens We next investigated whether TOP overexpression
would affect the presentation of other antigenic pep-from the transfected plasmids. E36 and L cells (DAP)
were chosen because they are readily infected with vac- tides. Overexpression of TOP in intact cells also inhib-
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Figure 2. TOP Overexpression Does Not Affect Cell Viability, Protein Synthesis, or Expression of HA
(A) E36-Kb were infected with vaccinia encoding gal (VV-gal), TOP (VV-TOP), or uninfected (none), or COS-Kb cells were untransfected
(none), or transfected with pTracerCMV (GFP), or pTracerCMV-TOP (TOP) as described in Figure 1, and viability was determined by exclusion
of trypan blue dye. Data are shown as the mean viability  SEM for multiple experiments.
(B) COS-Kb cells were transfected, or E36-Kb cells were infected, as described in Figure 1, and incorporation of 35S-methionine into protein
was measured as described in the Experimental Procedures. Data are displayed as the mean percent inhibition SEM for multiple experiments
of cells expressing TOP compared to a control protein (gal or ORP150).
(C) COS-Kb cells were transfected with pTracerCMV expressing TOP  GFP (TOP), ORP150  GFP (ORP150), or GFP alone (Vector), together
with pJFE14 expressing influenza HA. After 48 hr the cells were stained with anti-HA or an irrelevant antibody. The Bkg traces are cells stained
with an irrelevant antibody. In this same experiment, TOP inhibited the presentation of SIINFEKL (data not shown).
ited the presentation of the influenza-derived peptide coexpressed in COS-Kb cells with a plasmid that ex-
presses both ovalbumin and GFP or with SIINFEKL mini-ASNENMETM on H-2Db class I molecules (Figure 1D),
as well as the presentation on H-2Kb of a subdominant gene and GFP (data not shown), TOP overexpression
reduced the generation of SIINFEKL-Kb complexes (Fig-epitope from ovalbumin, KVVRFDKL (Figure 1E). Thus
TOP can reduce MHC class I presentation of at least ure 3D) but did not decrease the expression of GFP
(Figure 3E), further demonstrating that TOP overexpres-three antigenic peptides expressed from minigenes.
TOP-overexpressing cells showed no reduction in via- sion specifically affected MHC antigen presentation
rather than transfection efficiency or protein expression.bility, as judged by their exclusion of trypan blue (Figure
2A) and their normal rate of protein synthesis, as as- Thus, cytosolic TOP can inhibit the presentation of multi-
ple antigenic peptides that are generated by protea-sessed by incorporation of 35S-methionine/cysteine into
proteins (Figure 2B). Furthermore, when TOP was overex- somes from full-length proteins.
We have also compared the effects of overexpress-pressed with influenza hemagglutinin (HA), the amount of
HA expressed on the cell surface was not decreased ing TOP to those of overexpressing another cytosolic
peptidase. In cytosolic extracts, puromycin-sensitivebelow control levels (Figure 2C). Therefore, TOP overex-
pression is not toxic and can markedly decrease antigen aminopeptidase (PSA) was found to destroy certain anti-
genic peptides (though not SIINFEKL or several of itspresentation without interfering with plasmid transfec-
tion, expression of transfected genes, protein synthesis, N-extended precursors) (Saric et al., 2001), and PSA
was reported to trim certain N-extended precursors toprotein trafficking, or exocytosis.
the proper size for presentation (Stoltze et al., 2000).
COS-Kb cells were transfected with ovalbumin togetherEffect of TOP Overexpression on the Presentation
with a vector encoding PSA and GFP, and SIINFEKL-Kbof Peptides Generated from Full-Length Proteins
complexes were then quantified using the 25.D1.16 anti-Most MHC class I-presented peptides or their precur-
body. PSA transfection resulted in increased expressionsors are generated by proteasomes during breakdown
of PSA mRNA (data not shown) but did not reduce theof intracellular proteins (Cascio et al., 2001), and it is
presentation of SIINFEKL-Kb complexes on the cell sur-possible that proteasome-derived peptides are deliv-
face (Figure 3F), which is consistent with findings in cyto-ered directly to the peptide transporter TAP on the ER
solic extracts (Saric et al., 2001). Similar results were ob-membrane (Hirsch and Ploegh, 2000), that components
tained when PSA was cotransfected with the SIINFEKLof the proteasome complex protect antigenic peptides
minigene instead of full-length ovalbumin (Figure 3G).from cytosolic peptidases, or that the proteasome-gen-
Therefore, overexpression of any cytosolic peptidaseerated peptides might be preferentially bound by chap-
does not inevitably reduce antigen expression, but in-erones or other proteins that target them to the TAP
stead the effects depend on the particular enzyme (andtransporter. We therefore examined whether the presen-
perhaps the antigenic peptide).tation of SIINFEKL and KVVRFDKL, which were gener-
ated by proteasomes from whole ovalbumin, were af-
fected by the expression of TOP. TOP overexpression Effect of TOP on the Presentation of Peptides
in the ERmarkedly inhibited the presentation of both peptides
from ovalbumin in E36-Kb cells (Figures 3A and 3B) and TOP is a cytosolic enzyme and is not detected in the
ER even after transfection (Saric et al., 2002; data notalso reduced the presentation of ASNENMETM from full-
length influenza nucleoprotein (Figure 3C), which also shown). To test if the inhibition of antigen presentation
was in fact due to rapid hydrolysis of antigenic peptidesrequires proteasomes (Mo et al., 1999). When TOP was
Immunity
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Figure 3. TOP Transfection Inhibits MHC Class I Presentation of Peptides from Full-Length Antigen Constructs
(A) Similar to Figure 1C except cells were transfected with pCDNA3 encoding a full-length ovalbumin cDNA instead of the SIINFEKL minigene.
These data come from the same experiment as in Figure 1C. Although it has previously been reported that higher numbers of peptide-MHC
complexes are generated from minigenes than whole protein antigens (Anton et al., 1997), we have consistently failed to observe this
phenomenon in our system, possibly because of the longer times of antigen expression or different APCs.
(B) Similar to Figure 1E except cells were transfected for 2 hr with full-length ovalbumin cDNA (5 g) instead of SIINFEKL. These data come
from the same experiment as in Figure 1E.
(C) Similar to Figure 1D except cells were coinfected for 6 hr with vaccinia recombinants encoding TOP or gal and full-length influenza
nucleoprotein (gift from J. Yewdell, NIH) instead of ASNENMETM.
(D) Similar to Figure 1B except that ovalbumin was expressed instead of SIINFEKL, and the plasmid and inserts were reversed (ovalbumin
was expressed from pTracerCMV, and TOP, ORP150, or no insert was expressed from pcDNA). Expressing ovalbumin from pcDNA, and TOP,
ORP150, or no insert from pTracer, gave essentially identical effects on SIINFEKL-H-2Kb generation. MFI were Bkg, 3.84; Vector, 90.3; ORP150,
107; and TOP, 28.2.
(E) The same experiment as Figure 3D, showing the GFP fluorescence of the total population. With pTracerCMV, about half the transfected
cells express high levels of GFP. Transfection efficiency, about 30%, was low in this experiment. The curves for TOP, ORP150, and Vector
are superimposed on one another.
(F) COS-Kb cells were cotransfected with full-length ovalbumin in pCDNA3, and a pTracer CMV plasmid encoding GFP (Vector), or GFP 
human puromycin-sensitive aminopeptidase (PSA), and after 48 hr stained for SIINFEKLKb complexes with 25.D1.16 and analyzed by flow
cytometry. In this experiment pTracerCMV-TOP was also tested and inhibited antigen presentation by approximately 80%, as expected (data
not shown). MFI were Bkg, 6.2; PSA, 527; and Vector, 405 fluorescent units.
(G) Similar to Figure 3F except SIINFEKL minigene was expressed from the pcDNA3 vector. MFI were Bkg, 5.61; Vector, 233; PSA, 454
fluorescent units.
in the cytosol, we examined the effect of TOP transfec- transported into the ER (Anderson et al., 1991; Craiu et
al., 1997). The leader sequence then is removed by thetion on the presentation of an antigenic peptide that was
delivered directly into the ER, thus avoiding exposure to signal sequence peptidase acting by itself, or together
with the ER-resident aminopeptidase ERAP1 (Saric etcytosolic enzymes. A SIINFEKL minigene was expressed
in COS-Kb cells with an N-terminal signal sequence, which al., 2002; Serwold et al., 2002; York et al., 2002). Over-
expression of TOP did not inhibit the presentation of ER-causes the SIINFEKL peptide to be cotranslationally
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Figure 4. Overexpression of TOP Does Not
Reduce the Presentation of Peptides Gener-
ated in the ER or in Endosomes
(A) Similar to Figure 1B except cells were
transfected with a SIINFEKL minigene with
an N-terminal signal sequence instead of the
unmodified SIINFEKL minigene. These data
come from the same experiment as in Figure
1B. MFI were Bkg, 15.1; No OVA, 17; Vector,
1337; ORP150, 1395; and TOP ER-targeted
SIINFEKL, 1301 fluorescent units.
(B) I-Ad p41 invariant chain-expressing DAP
L cells were infected with vaccinia-TOP (TOP)
or vaccinia gal (gal), incubated with the
indicated concentrations of ovalbumin for 4
hr, and then fixed with paraformaldehyde.
The presence of ovalbumin I-Ad complexes
was detected by measuring the production
of IL-2 from the DO11.10 hybridoma (Shimon-
kevitz et al., 1983).
(C) Similar to Figure 1B except DAP-Kb cells
were used instead of E36-Kb and the incuba-
tion with antigen was 4 hr instead of 1.5 hr.
targeted SIINFEKL (Figure 4A), even though it markedly Consequently, conditions that limit the supply of pep-
reduced the presentation of SIINFEKL generated in the tides to MHC class I molecules (e.g., inhibition of the
cytoplasm (Figures 1B and 1C). Thus, TOP transfection proteasome [Rock et al., 1994] or of the TAP transporter
specifically inhibits the presentation of cytoplasmically [Townsend and Trowsdale, 1993])) reduce MHC appear-
derived peptides and does not nonspecifically affect ance on the cell surface. If TOP is destroying large num-
other steps needed for class I antigen presentation, such bers of antigenic peptides, there should be a reduction in
as MHC class I synthesis, assembly, or exocytosis (see MHC class I molecules on the cell surface. We therefore
also Figures 4A, 5B, and 5E, described below). analyzed the effect of TOP transfection on the total ex-
pression of MHC class I molecules on the cell surface.
Effect of TOP on the Presentation on MHC Class II We cotransfected into COS7 cells cDNAs for an MHC
Molecules of Peptides Generated class I molecule (either H-2Kb or HLA-A3) together with
in Endosomal Compartments TOP or a control vector, and after 48 hr measured the
We also tested the effect of TOP on MHC class II antigen expression of the MHC class I molecule on the trans-
presentation. In this pathway, peptides are generated fected cells. Overexpression of TOP caused a marked
by proteolysis in the endocytic compartment (Germain reduction in the levels of H-2Kb (Figure 5A) and HLA-A3
and Margulies, 1993), which does not contain TOP. L (Figure 5C) molecules on the cell surface. To confirm
cells (DAP) expressing the MHC class II molecule I-Ad, that this decrease in surface MHC class I molecules was
and the p41 isoform of invariant chain (Peterson and due to a reduction in the supply of antigenic peptides,
Miller, 1992), were both infected with vaccinia recombi- we coexpressed in these cells the ER-targeted SIINFEKL
nants expressing TOP or-galactosidase and incubated construct used in Figure 4A, which bypasses TOP in the
with different concentrations of ovalbumin added to the cytoplasm. In this situation, in which peptide supply to
medium. It has previously been shown that transfected
the SIINFEKL binding H-2Kb is restored, TOP overex-
L cells internalize exogenous ovalbumin, degrade it in
pression no longer reduces the levels of H-2Kb on theendocytic compartments, and present ovalbumin-derived
cell surface (Figure 5B), whereas the levels of HLA-A3peptides on the transfected class II molecules (Diment,
(which does not bind SIINFEKL) remain low (Figure 5D).1990; A. Sant, personal communication). Overexpres-
These results indicate that most MHC-presented pep-sion of TOP had little or no effect on the presentation
tides are susceptible to digestion by cytoplasmic pepti-to a specific T cell hybridoma of a class II-presented
dases and again confirm that high intracellular levels ofpeptides generated from ovalbumin (Figure 4B), even
TOP do not cause any general defects in MHC class Ithough in L cells it strongly inhibited the presentation
assembly or transport.on MHC class I molecules of SIINFEKL from full-length
In these experiments, MHC class I expression is re-ovalbumin or a minigene (Figure 4C).
duced on the cell surface presumably because TOP
limits the supply of peptides needed to stabilize MHCEffect of Overexpressing TOP on the Levels of Surface
class I molecules and allow their movement from theMHC Class I Molecules
ER to the cell surface. To further test this point, weNewly synthesized MHC class I molecules are retained
in the ER until they bind peptides (York and Rock, 1996). investigated whether TOP overexpression reduced the
Immunity
434
Figure 5. TOP Inhibits MHC Class I Assembly and Transport
(A) COS7 cells were cotransfected with H-2Kb in pcDNA3 and a pTracerCMV plasmid encoding GFP (Vector), OPR150  GFP (ORP150), or
TOP  GFP (TOP). The H-2Kb transfection was omitted in the background group (Bkg). After 48 hr the cells were stained with anti-H-2Kb (Y3)
and analyzed as described in Figure 1. MFI were Bkg, 22.7; Vector, 1922; ORP150, 1948; and TOP, 708 fluorescent units.
(B) Same as (A) except cells were also transfected with an ER-targeted signal sequence-SIINFEKL minigene. MFI were Bkg, 25.7; Vector,
1922; and TOP, 2151 fluorescent units.
(C) Similar to (A) except cells were transfected with pJFE14-HLA-A3 instead of H-2Kb and were stained with anti-HLA-A3 instead of anti-H-
2Kb. MFI were Bkg, 25.6; TOP, 89.9; ORP150, 211; and Vector, 237 fluorescent units.
(D) Same as (C) except cells were also transfected with a signal sequence-SIINFEKL minigene. MFI were Bkg, 25.6; TOP, 93.4; and vector,
244 fluorescent units. All panels are from the same experiment.
(E) DAP-Kb cells infected with vaccinia-TOP (TOP), vaccinia-gal (gal), or uninfected (none) were labeled with 35S-methionine and their MHC
class I molecules were immunoprecipitated from detergent lysates with an antibody that detects all free heavy chain (leftmost three lanes),
or with antibodies that detect only the indicated assembled MHC class I complexes (remaining lanes).
(F) The autoradiographs shown in (E) were scanned and densitometric analysis was performed.
assembly of stable MHC class I molecules. DAP-Kb cells Compared to cells infected with control vaccinia virus,
TOP overexpression minimally reduced the synthesis ofinfected with recombinant vaccinia virus expressing
TOP were also found to have a marked reduction in their MHC class I heavy chains (Figure 5E, leftmost three
lanes, and Figure 5F) or light chains (data not shown),surface expression of MHC class I molecules (data not
shown). These cells were infected with vaccinia virus but it did cause a marked reduction in assembled class
I H-2Dk, H-2Kk, and H-2Kb heterodimers (Figure 5E andexpressing TOP, or with vaccinia virus expressing-galac-
tosidase, and were then labeled with 35S-cysteine and 5F). The extent of the reduction in assembly varied for
different alleles, ranging from approximately 35% ofmethionine. The extent of assembly of the labeled MHC
class I molecules was investigated by immunoprecipita- control assembly for H-2Dk to about 55% of control
for H-2Kk. In other words, TOP overexpression (withouttion using antibodies specific for assembled MHC class
I molecules or the component heavy and light chains. affecting the synthesis of MHC class I heavy or light
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chains) reduces the assembly of stable MHC class I trol or TOP siRNA and examined the synthesis and
assembly of MHC class I molecules in a pulse-chasemolecules, presumably by causing the destruction of
many antigenic peptides in the cytosol. The difference experiment. Although the siRNA did not affect the syn-
thesis of MHC class I heavy chain (Figure 7A, upperin the magnitude of the effect between alleles may reflect
differing susceptibility of the peptides that bind to the panel), TOP siRNA increased the assembly of stable
complexes approximately 2-fold (Figure 7A, lower panel,particular alleles.
and Figure 7B).
Elimination of TOP from HeLa-Kb cells with siRNA in-Effect of Preventing TOP Expression
creased the levels on the cell surface of mouse H-2Kbon MHC Class I Presentation
(Figure 7C) by about 80%, and of human HLA-A, B, andThese results indicate that increasing the cellular con-
C molecules (Figure 7D) about 2-fold, as measured bytent of TOP by destroying antigenic peptides in the cyto-
flow cytometry. This increase in surface expression cor-sol reduces MHC class I presentation. In HeLa cell ex-
related well with the 2-fold increase in MHC class I as-tracts, the endogenous TOP is the peptidase primarily
sembly measured in immunoprecipitations (Figures 7Aresponsible for the rapid destruction of many synthetic
and 7B). Again, this effect was precisely opposite toantigenic peptides (Saric et al., 2001), and 9–17-residue
that observed when TOP was overexpressed in cellsproteasome products (T.S. et al., unpublished data). To
(Figure 5). Therefore, under physiological conditionsdetermine whether this enzyme, at the levels found nor-
TOP must destroy many antigenic peptides and gener-mally in cells, also hydrolyzes antigenic peptides and
ally limit antigen presentation.thus limits antigen presentation in vivo, we tested in
Hela-Kb cells whether selective elimination of TOP with
small interfering RNA (siRNA) oligonucleotides (Elbashir Discussion
et al., 2001) would increase antigen presentation. As a
control, we used siRNA directed against mouse TOP Together, the present findings demonstrate that TOP
whose sequence in this region is different from that of limits MHC class I antigen presentation by destroying
human TOP. Transfection of this control siRNA had no peptides in the cytoplasm. When overexpressed, TOP
effect on expression of human TOP. However, when inhibited only the presentation of peptides generated in
human TOP siRNA was transfected into HeLa-Kb cells, the cytosol and did not reduce the MHC class I presenta-
TOP mRNA was reduced by 85%–90% compared to tion of a peptide delivered directly into the ER or the
control siRNA-treated cells (Figure 6A) and TOP protein presentation on MHC class II molecules of a peptide
was reduced at least by 90% (the limit of sensitivity of generated in endocytic compartments. Also, TOP over-
the antibody), while several other assayed mRNAs (e.g., expression did not reduce overall protein synthesis, the
-actin and ERAP1 [data not shown]) and proteins (such production of MHC heavy or light chains, or the appear-
as calreticulin [Figure 6B]) were not affected. The trans- ance on the cell surface of an unrelated membrane pro-
fection efficiency of siRNA was estimated at 95% (data tein, influenza hemagglutinin. Therefore, TOP’s effects
not shown), so that even if TOP was completely elimi- are highly selective and are not due to some nonspecific
nated from transfected cells, 5% of control TOP levels or toxic effect on the cells.
would still be present in protein or RNA preparations. Increasing the cellular content of TOP inhibited the
HeLa-Kb cells were initially transfected with control or presentation of three well-defined antigenic peptides. It
TOP siRNA and 3 days later were transfected with a also reduced generally the assembly and surface ex-
plasmid coexpressing a SIINFEKL minigene and GFP. pression of many class I molecules, and this was due
Quantification of SIINFEKL-Kb complexes on trans- to a reduction in the supply of antigenic peptides be-
fected cells revealed that reducing TOP expression en- cause it was reversed when a MHC class I binding pep-
hanced the generation of these complexes nearly 2-fold tide was targeted by a signal sequence into the ER. It
(Figure 6C). Similarly, the presentation of SIINFEKL was is very unlikely that TOP reduces peptide supply to the
approximately doubled in TOP siRNA-treated cells ER by inhibiting the function of the TAP transporter di-
transfected with full-length ovalbumin (Figure 6D). These rectly because pure TOP only hydrolyzes oligopeptides
results, which are opposite to those seen when TOP and not proteins (Barrett et al., 1995). Therefore, the
expression is increased (Figure 1), indicate that under inhibition of antigen presentation when TOP levels rise
physiological conditions TOP normally limits the presen- is almost certainly due to accelerated degradation of
tation of SIINFEKL. Inhibition of TOP did not affect the proteasome products in the cytosol, which is consistent
expression of transfected influenza hemagglutinin (Fig- with the finding that TOP rapidly degrades many pep-
ure 6E), showing that the effect on SIINFEKL presenta- tides in cell extracts (Saric et al., 2001). Moreover, rapid
tion was not due to general effects on protein ex- destruction of antigenic peptides by TOP must occur
pression. normally in cells, since eliminating TOP with siRNA, or
by introducing selective inhibitors of TOP enzyme (data
not shown), enhanced the assembly and transport toEffect of Preventing TOP Expression on MHC Class I
Molecule Assembly and Surface Expression the cell surface of multiple MHC class I molecules, as
well as the presentation of a specific antigenic peptide.If TOP at physiological levels constantly destroys anti-
genic peptides or their longer precursors, then eliminat- Elimination of TOP with siRNA did not affect cell growth
or viability (data not shown), endogenous proteins wereing TOP should increase the supply of antigenic pep-
tides, which should in turn result in increased assembly synthesized at normal rates (e.g., MHC class I heavy
chain: Figure 7A, upper panel), and expression of aand surface expression of MHC class I molecules. To
test this hypothesis, we treated HeLa-Kb cells with con- transfected protein (influenza hemagglutinin: Figure 6E)
Immunity
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Figure 6. Loss of TOP Expression Enhances the Presentation of SIINFEKL on H-2Kb
(A) Four days after treatment with siRNA directed against human TOP (hTOP1; hTOP1  3) or with control siRNA (mTOP1: directed against
mouse TOP in a region not homologous to human TOP), mRNA was extracted from HeLa-Kb cells and cDNA was prepared. Real-time PCR
for human TOP, and for human -actin, was performed on the cDNA and on plasmids containing the appropriate genes for standardization.
The copy number of human TOP was normalized to -actin expression. Shown is the average of three experiments / standard deviation.
(B) Hela-Kb cells were treated with siRNA as in (A) and detergent lysates were prepared. 3-fold serial dilutions of the lysates were immunoblotted
with antibodies specific for TOP (upper panel) or calreticulin (lower panel).
(C) HeLa-Kb cells were transfected with the siRNA hTOP1, or with mTOP1 as a control. Three days later, the cells were transfected with
pTracerSR expressing the minigene SIINFEKL as well as GFP. After an additional day the cells were stained for SIINFEKL  Kb complexes
(25.D1.16), and GFP-positive cells were analyzed by flow cytometry as described in Figure 1. No OVA: cells transfected with pTracerSR
vector only and stained with 25.D1.16. Background fluorescence (based on staining with an irrelevant antibody) was very similar to that of
the No OVA group. MFI were Bkg, 12.2; TOP siRNA, 3826; and Ctrl siRNA, 2167 fluorescent units.
(D) Similar to (A) except that cells were transfected with pTracerSR expressing ovalbumin. MFI were Bkg, 38.8; hTOP, 2549, and Ctrl siRNA,
1647 fluorescent units.
(E) HeLa-Kb cells were transfected with the siRNA hTOP1, or with mTOP1 as a control. Two days later, the cells were transfected with
pTracerCMV (Bkg), or with pTracerCMV expressing influenza hemagglutinin. After an additional 2 days the cells were stained for hemagglutinin
and analyzed by flow cytometry. MFI were Bkg, 6.01; Ctrl siRNA, 5981; and hTOP siRNA, 5848 fluorescent units.
was unaffected by TOP inhibition. Although TOP nor- Although TOP has been known and characterized
enzymologically for many years and is present in virtuallymally limits the availability of most peptides for antigen
presentation, other still-unidentified cytosolic endopep- all mammalian cells (Carvalho and Camargo, 1981;
Orlowski et al., 1983; Camargo et al., 1997), its physio-tidases and aminopeptidases can hydrolyze antigenic
peptides in cell extracts (Saric et al., 2001) (T.S. et al., logical role(s) was unknown. Our data and related bio-
chemical studies on cell extracts (Saric et al., 2001) (T.S.unpublished data) and presumably in vivo, and may also
help limit the efficiency of antigen presentation. Thus, et al., unpublished data) clearly demonstrate that this
endopeptidase is responsible for hydrolyzing oligopep-antigenic peptides (and their longer precursors) appear
to resemble the great majority of peptides released from tides in the cytosol of cells. In the final steps in the
pathway for degradation of proteins, TOP appears toproteasomes in that they are subject to further rapid
degradation by cytosolic peptidases. cleave proteasome products of the sizes of antigenic
Endopeptidase Limits Antigen Presentation
437
Figure 7. Loss of TOP Expression Enhances Assembly and Surface Expression of Class I Molecules
(A) HeLa-Kb cells were transfected with the siRNAs hTOP1 and hTOP3, or with mTOP1 as a control. Three days later, the cells were radiolabeled
for 10 min and chased for 0, 15, or 45 min before lysis and immunoprecipitated with antibodies specific for unfolded heavy chain, or HLA-A,
B, and C assembled with 2-m, as described in Experimental Procedures.
(B) The autoradiographs from (A) were scanned and analyzed by densitometry.
(C) Hela-Kb cells were transfected with the siRNAs hTOP1 and hTOP3, or with mTOP1 as a control. Four days later, the cells were stained
with anti-H-2Kb (Y3) and phycoerythrin-anti-Ig antibodies and analyzed by flow cytometry as described in Figure 1. Bkg, background fluores-
cence, based on staining with an irrelevant antibody. MFI were Bkg, 4; TOP siRNA, 189; and Ctrl siRNA, 102 fluorescent units. (C) Similar to
(B) except that cells were stained with anti-HLA-A, B, C (PA2.6). MFI were Bkg, 4; TOP siRNA, 413; and Ctrl siRNA, 205 fluorescent units.
peptides or their precursors (9–17 residues) to pieces, cytosolic peptidases, such as TOP, and uptake into the
ER. It remains possible that there is some protection bymost of which are rapidly hydrolyzed by exopeptidases
to amino acids. cytosolic binding proteins (e.g., heat shock proteins)
(Srivastava et al., 1998). If so TOP, by destroying theAn important implication of our findings is that the
extent to which any particular peptide is presented on free peptide, may cause dissociation of bound peptides
and then further hydrolysis. The present findings andMHC class I molecules is a function both of its rate of
production and cytosolic destruction. A similar interplay our related biochemical studies (Saric et al., 2001) clearly
do not support the earlier report that TOP strongly bindsbetween peptide generation and destruction occurs in
the endocytic compartment for MHC class II presenta- antigenic peptides but does not efficiently degrade them
(Portaro et al., 1999). On this basis, it was even proposedtion (Vidard et al., 1991). Therefore, blocking TOP or
mutating sequences of antigens so that they become that TOP actually functions to facilitate peptide delivery
to TAP (Portaro et al., 1999; Silva et al., 1999). The rea-resistant to degradation by peptidases might be a useful
approach for enhancing antigen presentation and im- sons for these discrepant earlier observations are still
not clear (for a critical discussion, see Saric et al., 2001).mune responses to vaccines. On the other hand, it is also
possible that overproduction of TOP or other cytosolic While the destruction of antigenic peptides by TOP
and presumably other cytosolic peptidases can reducepeptidases may be a mechanism by which some can-
cers or viruses evade immune destruction, or may even MHC class I presentation and thus may appear to be
deleterious, this degradative process is probably an un-represent a novel approach for suppressing immune
response in transplanted cells or organs. avoidable consequence of the immune system utilizing
a phylogenetically older catabolic pathway whose prin-These findings argue that antigenic peptides and their
precursors are not protected by molecular chaperones cipal function in all cells is to break down proteins into
amino acids. On the other hand, for efficient generationfrom intracellular degradation in the cytosol or that if
such protective mechanisms do exist, they are not very of antigenic peptides, it may also be important that pro-
teasome products are free in the cytosol, since someeffective. How then do any antigenic peptides escape
destruction? In fact most probably don’t and are de- longer precursors to antigenic peptides have to be
trimmed by aminopeptidases to the MHC class I-pre-stroyed before binding to MHC molecules. Thus after
release from proteasomes, antigenic precursors con- sented epitopes (Beninga et al., 1998; Craiu et al., 1997;
Mo et al., 1999; Stoltze et al., 2000). Therefore, to thefront a kinetic competition between being cleaved by
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precipitation, and Western blotting were performed as previouslyextent that this N-terminal trimming occurs in the cyto-
described (York et al., 2002).plasm, peptides need to be accessible to peptidases.
In addition, this rapid destruction of antigenic pep-
Viability and Protein Synthesis Assays
tides by cytosolic peptidases may be an important factor Cell viability was determined by trypan blue exclusion. Protein syn-
in the regulation of immune responses. Under normal thesis was measured by the incorporation of 35S-methionine into
conditions most cells express very low levels of MHC TCA insoluble fractions as previously described (Rock et al., 1994).
class I, presumably because high constitutive expres-
Antigen Presentation Assayssion of these molecules might increase the danger of
Transfected and/or infected E36-Kb, E36-Db, or DAP-Kb APCs wereautoimmunity. In the absence of infection, peptide de-
fixed with 1% paraformaldehyde and incubated with antigen-spe-
struction will be one of the factors that helps to limit MHC cific T cell hybridomas as described (Craiu et al., 1997). After 18 hr,
class I antigen presentation. However, in the presence of the production of IL-2 from the hybridomas was measured using
inflammatory mediators, especially interferon-	, MHC CTLL2 cells as described (Craiu et al., 1997). These APCs were
chosen because they present well to the murine T-T hybridomasclass I presentation is enhanced, in part by inducing
and are highly infectable with vaccinia virus. SIINFEKLKb com-new proteasome subunits and the proteasome activator,
plexes were quantified on COS-Kb and Hela-Kb cells by immunofluo-PA28 (REG). The immunoproteasomes and complexes
rescence using a specific mAb (25.D1.16) (Porgador et al., 1997)
containing PA28 tend to produce more N-extended ver- because these xenogenic cells present poorly to our murine T-T
sions of antigenic peptides than “non-immune” protea- hybridomas but worked well in this staining assay.
somes (Cascio et al., 2002). Because these precursor
Antibodiespeptides are present in greater amounts and tend to
The monoclonal antibody 15.5.5 recognizes 2-microglobulin (2-be degraded more slowly by TOP and other cytosolic
m)-associated H-2Dk (Ozato et al., 1980); 16.1.1N recognizes 2-peptidases than the mature epitopes, they are more
m-associated H-2Kk (Ozato et al., 1980); and Y3 recognizes 2-m-likely to reach the ER and after trimming be presented
associated H-2Kb (Jones and Janeway, 1981). A rabbit antiserum
on MHC class I molecules. (Goldberg et al., 2002; Saric that recognizes unfolded mouse heavy chain was kindly provided
et al., 2001). by Stan Nathenson (Albert Einstein College of Medicine). The mono-
clonal antibody W6/32 (Parham et al., 1979) recognizes HLA-A, B,
and C alleles only in association with 2-m. HC10 (Stam et al., 1986)Experimental Procedures
recognizes unfolded HLA-B and C. Anti-TOP antiserum and the anti-
TOP monoclonal antibody IVD6 have been previously describedCells
(Conn et al., 1996).COS-Kb cells, HeLa-Kb, DAP-Kb, E36-Kb, and E36-Db cells were pre-
viously described (Michalek et al., 1993; Craiu et al., 1997; Mo et
al., 1999; York et al., 2002). DAP (L) cells expressing I-Ad and invariant Real-Time PCR
chain were a gift from Jim Miller (University of Rochester). mRNA was extracted from cells with an RNeasy kit (Qiagen, Valen-
cia, CA). cDNA was prepared using SuperScript II (Invitrogen). Real-
time PCR using Taq (Invitrogen) and an iCycler (BioRad, Hercules,Transfections and Infections
CA) was performed using primers directed against human TOPCOS7 or COS-Kb cells were transiently cotransfected with pTrac-
(ACTTCCCCCTCCTGAAGAAA and CCTTGAGGATAGCGCAGTTC)erCMV (Invitrogen) or pTracerSR (pTracerSV40 [Invitrogen] with an
or -actin (CGAGGCCCAGAGCAAGAGAG and CGGTTGGCCTTSR promoter [Takebe et al., 1988]) and pCDNA3 (Invitrogen) or
AGGGTTCAG).pJFE14 (Elliott et al., 1990) (1–2 g of each plasmid) expressing
enzymes, antigens, or MHC class I molecules, using FuGene6
Enzyme Assays(Roche, Indianapolis, IN) according to the manufacturer’s directions,
Enzymatic activities in cell extracts were measured as describedand incubated for 24–48 hr.
(Saric et al., 2001). The substrates used were, for TOP, Mcc-Pro-E36-Kb, E36-Db, or DAP-Kb APCs were infected with either vac-
Leu-Gly-Pro-D-Lys-Dnp-OH; for AP, Leu-Amc; for POP, Z-Gly-Pro-cinia-TOP or, as a control, vaccinia-gal (MOI 10) alone or in some
Amc; and for TPP-II, Ala-Ala-Phe-Amc.experiments together with vaccinia-T7 polymerase (MOI 10). Under
these conditions, 99  0.28% of the cells were infected with the
Acknowledgmentsvaccinia vectors. After 1.5–2 hr, antigen was introduced by infection
with a vaccinia recombinant. Alternatively, in the cells infected with
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